50,086 Shares in Xilio Therapeutics, Inc. (NASDAQ:XLO) Purchased by Raymond James Financial Inc.
Raymond James Financial Inc. purchased a new stake in shares of Xilio Therapeutics, Inc. (NASDAQ:XLO – Free Report) during the fourth quarter, Holdings Channel.com reports. The fund purchased 50,086 shares of the company’s stock, valued at approximately $48,000. A number of other institutional investors have also recently made changes to their positions in XLO. Renaissance […]
Raymond James Financial Inc. purchased a new stake in shares of Xilio Therapeutics, Inc. (NASDAQ:XLO – Free Report) during the fourth quarter, Holdings Channel.com reports. The fund purchased 50,086 shares of the company’s stock, valued at approximately $48,000. A number of other institutional investors have also recently made changes to their positions in XLO. Renaissance […]
